¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ´ç´¢º´ÇÐȸ Á¦32Â÷ Ãá°èÇмú´ëȸ : 2019-05-10

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ´ç´¢º´ÇÐȸ Á¦32Â÷ Ãá°èÇмú´ëȸ : 2019-05-10
±³À°ÀÏÀÚ : 2019-05-10
±³À°Àå¼Ò : °æÁÖ È­¹éÄÁº¥¼Ç¼¾ÅÍ  
±³À°ÁÖÁ¦ : ´ëÇÑ´ç´¢º´ÇÐȸ Á¦32Â÷ Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : ÀÌ¿¬ÁÖ
¿¬¶ôó : 02-714-9071  
À̸ÞÀÏ : diabetes@kams.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : °æ»óºÏµµ
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 250,000¿ø      
ºñ°í »çÀüµî·Ï: Àü¹®ÀÇ-ȸ¿ø 130,000¿ø/ºñȸ¿ø 200,000¿ø »çÀüµî·Ï: Àü°øÀÇ ¹× ±âŸ-ȸ¿ø 70,000¿ø/ºñȸ¿ø 90,000¿ø ÇöÀåµî·Ï: Àü¹®ÀÇ-ȸ¿ø 200,000¿ø/ºñȸ¿ø 250,000¿ø ÇöÀåµî·Ï: Àü°øÀÇ ¹× ±âŸ-ȸ¿ø 90,000¿ø/ºñȸ¿ø 110,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room6 09:00~09:25 Overview: understanding the relationship between ¥â Cell dynamics and diabetes  °­½Å¾Ö(¿¬¼¼ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room6 09:25~09:50 GLP1 increases b cell regeneration by promoting a to b treansdifferentiation  ÀüÈñ¼÷(°¡ÃµÀÇ´ë ¾Ï´ç´¢¿¬±¸¿ø) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room6 09:50~10:15 Dynamic pathology of islet endocrine cells in diabetes  ¿ø±ÔÀå(¿µ³²ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room6 10:15~10:40 SREBP1c-PAX4 Axis in ¥â cell compensation  ±èÀç¹ü(¼­¿ï´ë »ý¸í°úÇкÎ) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1,2 11:30~12:10 Bring the spotlight onto a niche in diabetes research  ±èÀÎÁÖ(ºÎ»êÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room5 12:30~13:10 Managing diabetes in elderly: go easy and individualizes  ÀÌ¿ëÈ£(¿¬¼¼ÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1 14:10~14:35 Should adults with type 2 diabetes be screened for atherosclerotic cardiovascular disease? - respect of cardiologist  Á¶Áø¸¸(°æÈñÀÇ´ë ½ÉÀå³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1 14:35~15:00 Should adults with type 2 diabetes be screened for atherosclerotic cardiovascular disease? - respect of endocrinologist  ¼­¼ºÈ¯(µ¿¾ÆÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1 15:00~15:25 Does extreme risk category for CVD need for dyslipidemia management in Korean type 2 diabetic patients? - pro  ¹Úö¿µ(¼º±Õ°üÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room1 15:25~15:50 Does extreme risk category for CVD need for dyslipidemia management in Korean type 2 diabetic patients? - cons  ¹®¹Î°æ(¼­¿ïÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room4 16:10~16:35 Urinary EV miRNA in the prediction of DKD progression  ÀÌ´ëÈ£(°¡ÃµÀÇ´ë ³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room4 16:35~17:00 RNA sequence tramscriptome in DKD  ¹Ú¹Ì¿µ(ºÎ»ê´ë ÀÇ»ý¸í¿¬±¸¿ø) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room4 17:00~17:25 Role of ACE2 in diabetic kidney disease  ¹èÀºÈñ(Àü³²ÀÇ´ë ½ÅÀå³»°ú) 
±³À°½Ã°£ 05-10 °æÁÖÇÏÀÌÄÚ Room4 17:25~17:50 Basic research in degenerative eye disease in diabetes  ¹ÚÅ°ü(¼øõÇâÀÇ´ë ¾È°ú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ´ç´¢º´ÇÐȸ Á¦32Â÷ Ãá°èÇмú´ëȸ : 2019-05-10""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û »ï¼º¼­¿ïº´¿ø 2019 »ï¼º ¾È°ú ±Ý¿äÁý´ãȸ(¾È°úºÐ¾ßÀÇ ÀΰøÁö´É) : 2019-05-10
´ÙÀ½±Û ±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»ç Áý´ãȸ(°æºÎÀÓÆļ±¿°) : 2019-05-10
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
60 ºÎ»ê 2018³â ´ëÇѼÒÈ­±â¿¬°üÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2018-08-18 0 675 2018-07-28
59 ¼­¿ï ´ëÇÑ»êºÎÀΰúÀÇ»çȸ&Çѱ¹¹ß»ý»ý¹°ÇÐȸ Joint Symposium : 2018-08-18 0 1,080 2018-07-28
58 ¼­¿ï ´ëÇѺ´¸®ÇÐȸ 8th Ç÷¾×º´¸® ¿¬¼ö±³À° : 2018-08-18 0 706 2018-07-28
57 ¼­¿ï ´ëÇѴٹ߼º°æÈ­ÁõÇÐȸ 2018³â ¿¬·ÊÇмú´ëȸ : 2018-08-18 0 835 2018-07-28
56 ¼­¿ï ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ 2018³âµµ Á¦2Â÷ ÁöµµÀü¹®ÀÇ ±³À° : 2018-08-17 0 857 2018-07-28
55 °­¿ø ´ëÇѽÉÀåÇÐȸ Ç÷°ü¿¬±¸È¸ ÇÏ°è½ÉÆ÷Áö¾ö : 2018-08-17 0 1,286 2018-07-28
54 ¼­¿ï Á߾Ӵ뺴¿ø »êºÎÀΰú žÆÃÊÀ½ÆÄ ¿¬¼Ó°­Á : 2018-08-16 0 659 2018-07-28
53 ¼­¿ï °Ç±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ ¿¬¼ö±³À°(ÈĵÎÁúȯ) : 2018-08-16 0 728 2018-07-28
52 ¼­¿ï ´ëÇÑÀÇ»çÇùȸ [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] °Ç°­º¸Çè ¼ö°¡°áÁ¤ : 2018-08-16 0 865 2018-07-28
51 ¼­¿ï Çѱ¹¿ªÇÐȸ Biomarker ¸¦ ÀÌ¿ëÇÑ ¿¬±¸ ¼³°è¿Í ºÐ¼® : 2018-08-14 0 1,277 2018-07-28
50 ¼­¿ï Á¦240ȸ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ¿ù·Ê ÇмúÁý´ãȸ : 2018-08-14 0 423 2018-07-28
49 ¼­¿ï Çѱ¹¿ªÇÐȸ MR ±â¹Ý À¯Àüü ¿ªÇבּ¸¿Í °ø°ø°Ç°­ÀÚ·á ±â¹Ý Outcome research : 2018-08-13 0 646 2018-07-28
48 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø 2018 Catholic Orthopedic Symposium II - Foot & Ankle, Hip, Knee - : 2018-08-12 0 1,100 2018-07-28
47 ¼­¿ï 2018 ´ëÇÑÈäºÎ¿µ»óÀÇÇÐȸ ¿¬¼ö°­Á : 2018-08-12 0 539 2018-07-28
46 ¼­¿ï 2018 Á¦ 2ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ ±¹Á¦½ÉÆ÷Áö¾ö : 2018-08-11 0 1,421 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷